The utility of omega-3 fatty acids in cardiovascular disease

American Journal of Therapeutics

Volumn 16, Issue 5, 2009, Pages 421-436

  Saremi, Adonis ^a   Arora, Rohit ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; DHA; EPA; Omega 3 fatty acids

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; CORN OIL; DOCOSAHEXAENOIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLMERCURY; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; WARFARIN;

ANTIARRHYTHMIC ACTIVITY; ANTIATHEROGENIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTITRIGLYCERIDEMIC ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG ACTIVITY; DRUG MECHANISM; FISH; FOOD AND DRUG ADMINISTRATION; FOOD INTAKE; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEMOSTATIC ACTIVITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL VALUE; PREGNANT WOMAN; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SECONDARY PREVENTION; STROKE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION INHIBITION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CARDIOVASCULAR DISEASES; CHILD; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; FISHES; HUMANS; NUTRITION POLICY; PREGNANCY; UNITED STATES;

EID: 70349685267     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3180a5f0bb     Document Type: Review

References (44)

1. Devlin, Thomas M. Textbook of Biochemistry with Clinical Correlations, 3rd ed. New York: John Wiley & Sons, Inc; 1992:389-470.
2. Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332: 977-982.
3. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23-28.
4. Guallar E, Aro A, Jimenez FJ, et al. Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: the EURAMIC study. Arterioscler Thromb Vasc Biol. 1999;19: 1111-1118.
5. Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol. 1997;145:876-887.
6. Stone NJ. Fish consumption, fish oil, lipids, and coronary heart disease. Circulation. 1996;94:2337-2340.
7. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.
8. Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol. 1995;24: 340-345.
9. Shekelle RB, Missell L, Paul O, et al. Fish consumption and mortality from coronary heart disease [Letter]. N Engl J Med. 1985;313:820.
10. Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet. 1991;66: 205-216.
11. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336:1046-1053. (Pubitemid 27163856)
12. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287:1815-1821.
13. Oomen CM, Feskens EJ, Rasanen L, et al. Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. Am J Epidemiol. 2000;151:999-1006.
14. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363-1367.
15. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-1118.
16. Landmark K, Abdelnoor M, Kilhovd B, et al. Eating fish may reduce infarct size and the occurrence of Q wave infarcts. Eur J Clin Nutr. 1998;52:40-44.
17. Landmark K, Abdelnoor M, Urdal P, et al. Use of fish oils appears to reduce infarct size as estimated from peak creatine kinase and lactate dehydrogenase activities. Cardiology. 1998;89:94-102.
18. Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke: the Zutphen Study. Stroke. 1994;25: 328-332. (Pubitemid 24047253)
19. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001;285:304-312.
20. Orencia AJ, Daviglus ML, Dyer AR, et al. Fish consumption and stroke in men: 30-year findings of the Chicago Western Electric Study. Stroke. 1996;27:204-209.
21. Morris MC, Manson JE, Rosner B, et al. Fish consumption and cardiovascular disease in the Physicians' Health Study: a prospective study. Am J Epidemiol. 1995;142: 166-175.
22. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-2757.
23. Nilsen DW, Albrektsen G, Landmark K, et al. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr. 2001;74:50-56.
24. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet. 1989;2:757-761.
25. Burr ML, Sweetham PM, Fehily AM. Diet and reinfarction. Eur Heart J. 1994;15:1152-1153.
26. Singh RB, Niaz MA, Sharma JP, et al. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther. 1997;11:485-491.
27. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999; 354:447-455.
28. Bucher HC, Hengstler P, Schindler C, et al. N-3 polyunsaturated fatty acids in coronary heart disease: a metaanalysis of randomized controlled trials. Am J Med. 2002; 112:298-304. (Pubitemid 34219443)
29. Wang C, Chung M, Balk E, et al. N-3 fatty acids from fish or fish-oil supplements, but not a-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary- prevention studies: a systematic review. Am J Clin Nutr. 2006;83:5-17.
30. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65(Suppl):1645S- 1654S.
31. Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care. 2000;23:1407-1415.
32. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993;88:523-533.
33. Appel LJ, Miller ER 3rd, Seidler AJ, et al. Does supplementation of diet with -fish oil- reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993;153:1429-1438.
34. Knapp HR. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr. 1997;65 (Suppl):1687S-1698S.
35. Shahar E, Folsom AR, Wu KK, et al. Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1993;13: 1205-1212.
36. Archer SL, Green D, Chamberlain M, et al. Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol. 1998;18:1119-1123.
37. Johansen O, Seljeflot I, Hostmark AT, et al. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vas Biol. 1999;19:1681-1686.
38. Christensen JH, Gustenhoff P, Korup E, et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ. 1996;312:677-678.
39. Grimsgaard S, Bonaa KH, Hansen JB, et al. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr. 1998;68:52-59.
40. Eritsland J, Arnesen H, Gronseth K, et al. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol. 1996;77:31-36.
41. Abe Y, El-Masri B, Kimball KT, et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential signifi- cance on monocyte adhesion. Arterioscler Thromb Vasc Biol. 1998;18:723-731.
42. Foran JA, Carpenter DO, Hamilton MC, et al. Risk-based consumption advice for farmed Atlantic and wild Pacific salmon contaminated with dioxins and dioxin-like compounds. Environ Health Perspect. 2005;113:552-556.
43. US Department of Health and Human Services, Food and Drug Administration, Center for Food Safety and Applied Nutrition. What You Need to Know About Mercury in Fish and Shellfish- 2004 EPA and FDA Advice For: Women Who Might Become Pregnant, Women Who are Pregnant, Nursing Mothers, Young Children. Available at: www.cfsan.fda.gov/;dms/admehg3.html. Accessed December 2, 2006.
44. US Food and Drug Administration. Mercury in fish: cause for concern? FDA Consumer. 1994;28(September). Revised May 1995. Available at: www.fda.gov/fdac/reprints/mercury.html. Accessed October 7, 2002.